1. Home
  2. HLX vs ALVO Comparison

HLX vs ALVO Comparison

Compare HLX & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Helix Energy Solutions Group Inc.

HLX

Helix Energy Solutions Group Inc.

HOLD

Current Price

$8.64

Market Cap

1.4B

Sector

Energy

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.92

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLX
ALVO
Founded
1979
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HLX
ALVO
Price
$8.64
$3.92
Analyst Decision
Strong Buy
Buy
Analyst Count
2
4
Target Price
$11.50
$8.00
AVG Volume (30 Days)
1.3M
1.0M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$876,561,000.00
N/A
Revenue This Year
$2.05
$13.28
Revenue Next Year
$5.46
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
3.60
N/A
52 Week Low
$5.52
$2.94
52 Week High
$10.75
$9.94

Technical Indicators

Market Signals
Indicator
HLX
ALVO
Relative Strength Index (RSI) 34.57 55.06
Support Level $8.58 $3.09
Resistance Level $10.54 $4.17
Average True Range (ATR) 0.34 0.32
MACD -0.09 0.03
Stochastic Oscillator 14.08 59.39

Price Performance

Historical Comparison
HLX
ALVO

About HLX Helix Energy Solutions Group Inc.

Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. The Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S., and it also has its presence in North Sea, Brazil, Asia Pacific, West Africa, and Other.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: